Published in Physician Law Weekly, August 9th, 2006
The patent relates to Forest's Lexapro product.
Forest has received notification from Caraco Pharmaceutical Laboratories, Ltd., that it filed an abbreviated new drug application with a Paragraph IV certification for a generic equivalent to Lexapro.
Howard Solomon, chairman and CEO of Forest, said: "We believe the patent on Lexapro is valid and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Physician Law Weekly